Editorial: Nonalcoholic fatty liver disease: From pathogenesis to phytomedicine based on omics technology

Front Pharmacol. 2022 Oct 21:13:1062979. doi: 10.3389/fphar.2022.1062979. eCollection 2022.

Authors

Guang Ji¹, Guoxiang Xie², Tao Wu³, Yunping Qiu⁴

Affiliations

¹ Institute of Digestive Disease, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
² University of Hawaii Cancer Center, Honolulu, HI, United States.
³ Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
⁴ Albert Einstein College of Medicine, New York City, NY, United States.

No abstract available

Keywords: NAFLD; experimental pharmacology; omics; pathogenesis; phytomedicine.

Publication types

Editorial